Could researchers develop a vaccine to lower bad cholesterol (LDL)?

Cholesterol vaccines are being studied as a potential long-term approach to lowering LDL cholesterol and reducing cardiovascular risk. In this episode, we examine how these investigational therapies work and how cholesterol management is assessed in Europe.

In this episode, we cover:

• What LDL cholesterol is and how it contributes to atherosclerosis

• How current treatments work (statins, ezetimibe, PCSK9 inhibitors)

• The science behind cholesterol-targeting vaccines

• Early-stage research and clinical trial status

• Potential advantages and limitations of long-acting therapies

• Safety considerations and regulatory approval pathways

• When lifestyle modification remains first-line

• Situations where treatment requests may be declined pending testing

Doctors assess lipid profile results, blood pressure, smoking status, diabetes risk, family history, and overall cardiovascular risk (e.g., SCORE2) before recommending treatment. Experimental vaccines are not available in routine clinical practice and cannot be prescribed via telemedicine.

This episode reflects how cholesterol and heart disease risk are evaluated through structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/could-researchers-develop-a-vaccine-to-lower-bad-cholesterol